Noonan syndrome and related disorders: Genetics and pathogenesis

被引:253
作者
Tartaglia, M [1 ]
Gelb, BD
机构
[1] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy
[2] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
关键词
PTPN11; SHP-2; signal transduction;
D O I
10.1146/annurev.genom.6.080604.162305
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Noonan syndrome is a pleiomorphic autosomal dominant disorder with short stature, facial dysmorphia, webbed neck, and heart defects. In the past decade, progress has been made in elucidating the pathogenesis of this disorder using a positional cloning approach. Noonan syndrome is now known to be a genetically heterogeneous disorder with nearly one half of cases caused by gain-of-function mutations in PTPN11, the gene encoding the protein tyrosine phosphatase SHP-2. Similar germ line mutations cause two related genetic disorders, Noonan-like disorder with multiple giant cell lesion syndrome and LEOPARD syndrome, and somatic PTPN11 mutations can underlie certain pediatric hematopoietic malignancies, including juvenile myelomonocytic, acute lymphoblastic, and acute myelogenous leukemias. A mouse model of PTPN11-related Noonan syndrome was recently generated, providing a reagent for studying disease pathogenesis in greater depth as well as experimenting with novel therapeutic strategies.
引用
收藏
页码:45 / 68
页数:28
相关论文
共 103 条
[1]   Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population [J].
Adekunle, O ;
Gopee, A ;
El-Sayed, M ;
Thilaganathan, B .
BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (857) :457-460
[2]   NOONAN SYNDROME - THE CHANGING PHENOTYPE [J].
ALLANSON, JE ;
HALL, JG ;
HUGHES, HE ;
PREUS, M ;
WITT, RD .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 21 (03) :507-514
[3]   Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation [J].
Araki, T ;
Mohi, MG ;
Ismat, FA ;
Bronson, RT ;
Williams, IR ;
Kutok, JL ;
Yang, WT ;
Pao, LI ;
Gilliland, DG ;
Epstein, JA ;
Neel, BG .
NATURE MEDICINE, 2004, 10 (08) :849-857
[4]   A RECURRENT MUTATION IN THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH-FACTOR RECEPTOR-3 CAUSES HYPOCHONDROPLASIA [J].
BELLUS, GA ;
MCINTOSH, I ;
SMITH, EA ;
AYLSWORTH, AS ;
KAITILA, I ;
HORTON, WA ;
GREENHAW, GA ;
HECHT, JT ;
FRANCOMANO, CA .
NATURE GENETICS, 1995, 10 (03) :357-359
[5]   PROTEIN-TYROSINE-PHOSPHATASE SHPTP2 COUPLES PLATELET-DERIVED GROWTH-FACTOR RECEPTOR-BETA TO RAS [J].
BENNETT, AM ;
TANG, TL ;
SUGIMOTO, S ;
WALSH, CT ;
NEEL, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7335-7339
[6]   Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation [J].
Bertola, DR ;
Pereira, AC ;
de Oliveira, PSL ;
Kim, CA ;
Krieger, JE .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 130A (04) :378-383
[7]  
Bertola DR, 2001, AM J MED GENET, V98, P230, DOI 10.1002/1096-8628(20010122)98:3<230::AID-AJMG1080>3.0.CO
[8]  
2-K
[9]   Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis [J].
Chen, BB ;
Bronson, RT ;
Klaman, LD ;
Hampton, TG ;
Wang, JF ;
Green, PJ ;
Magnuson, T ;
Douglas, PS ;
Morgan, JP ;
Neel, BG .
NATURE GENETICS, 2000, 24 (03) :296-299
[10]   Identification of Shp-2 as a Stat5A phosphatase [J].
Chen, Y ;
Wen, RR ;
Yang, S ;
Shuman, J ;
Zhang, EE ;
Yi, TL ;
Feng, GS ;
Wang, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :16520-16527